Toward a positive psychology of psychoactive drug use

References

• Ahern, J., Stuber, J., & Galea, S. (2007). Stigma, discrimination and the health of illicit drug users. Drug and Alcohol Dependence, 88(2–3), 188–196. https://doi.org/10.1016/j.drugalcdep.2006.10.014
   PubMed Web of Science ®Google Scholar
• Alexander, B. K. (2010). The globalization of addiction: A study in poverty of the spirit. Oxford University Press.
   Google Scholar
• American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Association.
   Google Scholar
• Anderson, D. M., Hansen, B., Rees, D. I., & Sabia, J. J. (2019). Association of marijuana laws with teen marijuana use: New estimates from the youth risk behavior surveys. JAMA Pediatrics, 173(9), 879–881. https://doi.org/10.1001/jamapediatrics.2019.1720
   PubMed Web of Science ®Google Scholar
• Askew, R. (2016). Functional fun: Legitimising adult recreational drug use. The International Journal on Drug Policy, 36, 112–119. https://doi.org/10.1016/j.drugpo.2016.04.018
   PubMed Web of Science ®Google Scholar
• Askew, R., & Williams, L. (2020). Rethinking enhancement substance use: A critical discourse studies approach. International Journal of Drug Policy, 95, 102994.
   PubMed Web of Science ®Google Scholar
• Banaschewski, T., Blomeyer, D., Buchmann, A. F., Poustka, L., Rothenberger, A., & Laucht, M. (2011). Drugs as instruments from a developmental child and adolescent psychiatric perspective. Behavioral and Brain Sciences, 34(6), 312–313. https://doi.org/10.1017/S0140525X11000690
   PubMed Web of Science ®Google Scholar
• Beck, J. (1998). 100 years of “just say no” versus “just say know”. Reevaluating drug education goals for the coming century. Evaluation Review, 22(1), 15–45. https://doi.org/10.1177/0193841X9802200102
   PubMed Web of Science ®Google Scholar
• Becker, H. S. (1953). Becoming a marihuana user. American Journal of Sociology, 59(3), 235–403. https://doi.org/10.1086/221326
   Web of Science ®Google Scholar
• Bogenschutz, M. P., & Johnson, M. W. (2016). Classic hallucinogens in the treatment of addictions. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 64, 250–258. https://doi.org/10.1016/j.pnpbp.2015.03.002
   PubMed Web of Science ®Google Scholar
• Bok, M., & Morales, J. (2000). Harm reduction: Dealing differently with adolescents and youth. Journal of HIV/AIDS Prevention & Education for Adolescents & Children, 3(3), 87–99. https://doi.org/10.1300/J129v03n03_06
   Google Scholar
• Borg, J., Andrée, B., Soderstrom, H., & Farde, L. (2003). The serotonin system and spiritual experiences. American Journal of Psychiatry, 160(11), 1965–1969. https://doi.org/10.1176/appi.ajp.160.11.1965
   PubMed Web of Science ®Google Scholar
• Bright, S. J., Kane, R., Bishop, B., & Marsh, A. (2014). Development of the Australian dominant drug discourses scale. Addiction Research & Theory, 22(5), 416–423. https://doi.org/10.3109/16066359.2013.873792
   Web of Science ®Google Scholar
• Bright, S. J., Marsh, A., Smith, L. M., & Bishop, B. (2008). What can we say about substance use? Dominant discourses and narratives emergent from Australian media. Addiction Research & Theory, 16(2), 135–148. https://doi.org/10.1080/16066350701794972
   Web of Science ®Google Scholar
• Brown, K. W., & Ryan, R. M. (2003). The benefits of being present: Mindfulness and its role in psychological well-being. Journal of Personality and Social Psychology, 84(4), 822–848. [Database] https://doi.org/10.1037/0022-3514.84.4.822
   PubMed Web of Science ®Google Scholar
• Canal, C. E., & Murnane, K. S. (2017). The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens. Journal of Psychopharmacology, 31(1), 127–143. https://doi.org/10.1177/0269881116677104
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R. L., & Nutt, D. J. (2010). User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study. Journal of Substance Use, 15(4), 283–300. https://doi.org/10.3109/14659890903271624
   Web of Science ®Google Scholar
• Carhart-Harris, R. L., Kaelen, M., Bolstridge, M., Williams, T. M., Williams, L. T., Underwood, R., Feilding, A., & Nutt, D. J. (2016). The paradoxical psychological effects of lysergic acid diethylamide (LSD). Psychological Medicine, 46(7), 1379–1390. https://doi.org/10.1017/S0033291715002901
   PubMed Web of Science ®Google Scholar
• Chatwin, C., & Porteous, D. (2013). Insiders? The experiences and perspectives of long-term, regular cannabis users. Contemporary Drug Problems, 40(2), 235–257. https://doi.org/10.1177/009145091304000205
   Google Scholar
• Clifford, P. R., Edmundson, E. W., Koch, W. R., & Dodd, B. G. (1991). Drug use and life satisfaction among college students. International Journal of the Addictions, 26(1), 45–53. https://doi.org/10.3109/10826089109056238
   PubMed Web of Science ®Google Scholar
• Cohen, S. (1985). LSD: The varieties of psychotic experience. Journal of Psychoactive Drugs, 17(4), 291–296. https://doi.org/10.1080/02791072.1985.10524333
   PubMed Web of Science ®Google Scholar
• Coley, R. L., Kruzik, C., Ghiani, M., Carey, N., Hawkins, S. S., & Baum, C. F. (2020). Recreational marijuana legalization and adolescent use of marijuana, tobacco, and alcohol. Journal of Adolescent Health, 69(1), 41–49.
   PubMed Web of Science ®Google Scholar
• Cooper, M. L. (1994). Motivations for alcohol use among adolescents: Development and validation of a four-factor model. Psychological Assessment, 6(2), 117–128. https://doi.org/10.1037/1040-3590.6.2.117
   Google Scholar
• Cooper, M. L., Frone, M. R., Russell, M., & Mudar, P. (1995). Drinking to regulate positive and negative emotions: A motivational model of alcohol use. Journal of Personality and Social Psychology, 69(5), 990–1005. https://doi.org/10.1037/0022-3514.69.5.990
   Google Scholar
• Courtwright, D. T. (2005). Mr. ATOD’s wild ride: What do alcohol, tobacco, and other drugs have in common? The Social History of Alcohol and Drugs, 20, 105–140. https://doi.org/10.1086/SHAD20010105
   PubMedGoogle Scholar
• Cox, W. M., & Klinger, E. (1988). A motivational model of alcohol use. Journal of Abnormal Psychology, 97(2), 168–180. [Database] https://doi.org/10.1037/0021-843X.97.2.168
   PubMed Web of Science ®Google Scholar
• Csete, J., Kamarulzaman, A., Kazatchkine, M., Altice, F., Balicki, M., Buxton, J., Cepeda, J., Comfort, M., Goosby, E., Goulão, J., Hart, C., Kerr, T., Lajous, A. M., Lewis, S., Martin, N., Mejía, D., Camacho, A., Mathieson, D., Obot, I., … Beyrer, C. (2016). Public health and international drug policy. Lancet, 387(10026), 1427–1480. https://doi.org/10.1016/S0140-6736(16)00619-X
   PubMed Web of Science ®Google Scholar
• Csikszentmihalyi, M. (1990). Flow: The psychology of optimal experience. Harper & Row.
   Google Scholar
• Cummins, C., & Lyke, J. (2013). Peak experiences of psilocybin users and non-users. Journal of Psychoactive Drugs, 45(2), 189–194. https://doi.org/10.1080/02791072.2013.785855
   PubMed Web of Science ®Google Scholar
• Dalgarno, P., & Shewan, D. (2005). Reducing the risks of drug use: The case for set and setting. Addiction Research & Theory, 13(3), 259–265. https://doi.org/10.1080/16066350500053562
   Web of Science ®Google Scholar
• De la Torre, R., Farré, M., Roset, P. N., Pizarro, N., Abanades, S., Segura, M., Segura, J., & Camí, J. (2004). Human pharmacology of MDMA: Pharmacokinetics, metabolism, and disposition. Therapeutic Drug Monitoring, 26(2), 137–144. https://doi.org/10.1097/00007691-200404000-00009
   PubMed Web of Science ®Google Scholar
• Dennis, F. (2017). Conceiving of addicted pleasures: A ‘modern’ paradox. The International Journal on Drug Policy, 49, 150–159. https://doi.org/10.1016/j.drugpo.2017.07.007
   PubMed Web of Science ®Google Scholar
• El-Seedi, H. R., De Smet, P. A., Beck, O., Possnert, G., & Bruhn, J. G. (2005). Prehistoric peyote use: Alkaloid analysis and radiocarbon dating of archaeological specimens of Lophophora from Texas. Journal of Ethnopharmacology, 101(1–3), 238–242. https://doi.org/10.1016/j.jep.2005.04.022
   PubMed Web of Science ®Google Scholar
• Engel, L. B., Bright, S. J., Barratt, M. J., & Allen, M. M. (2020). Positive drug stories: Possibilities for agency and positive subjectivity for harm reduction. Addiction Research & Theory, 29, 1–9.
   Web of Science ®Google Scholar
• Exline, J. J. (2016). Forgiveness and the ego: Why hypo-egoic states foster forgiveness and prosocial responses. In K. W. Brown & M. R. Leary (Eds.), The Oxford handbook of hypo-egoic phenomena (pp. 257–269). Oxford University Press.
   Google Scholar
• Gable, R. S. (2004). Acute toxic effects of club drugs. Journal of Psychoactive Drugs, 36(3), 303–313. https://doi.org/10.1080/02791072.2004.10400031
   PubMed Web of Science ®Google Scholar
• Gable, R. S. (2006). The toxicity of recreational drugs. American Scientist, 94(3), 206–208. https://doi.org/10.1511/2006.59.206
   Web of Science ®Google Scholar
• Gable, S. L., & Haidt, J. (2005). What (and why) is positive psychology? Review of General Psychology, 9(2), 103–110. https://doi.org/10.1037/1089-2680.9.2.103
   Web of Science ®Google Scholar
• Goodman, N. (2002). The serotonergic system and mysticism: Could LSD and the nondrug-induced mystical experience share common neural mechanisms? Journal of Psychoactive Drugs, 34(3), 263–272. https://doi.org/10.1080/02791072.2002.10399962
   PubMed Web of Science ®Google Scholar
• Government of British Columbia. (2010). Healthy minds, healthy people: A ten-year plan to address mental health and substance use in British Columbia. http://www.health.gov.bc.ca/library/publications/year/2010/healthy_minds_healthy_people.pdf
   Google Scholar
• Green, B. O. B., Kavanagh, D., & Young, R. (2003). Being stoned: A review of self-reported cannabis effects. Drug and Alcohol Review, 22(4), 453–460. https://doi.org/10.1080/09595230310001613976
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology, 30(12), 1181–1197. https://doi.org/10.1177/0269881116675513
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187(3), 268–283. https://doi.org/10.1007/s00213-006-0457-5
   PubMed Web of Science ®Google Scholar
• Grinspoon, L., & Bakalar, J. B. (1979). Psychedelic drugs reconsidered. Basic Books.
   Google Scholar
• Grund, J. P. C. (1993). Drug use as social ritual: Functionality, symbolism and determinants of self-regulation. IVO.
   Google Scholar
• Haden, M., Emerson, B., & Tupper, K. W. (2016). A public-health-based vision for the management and regulation of psychedelics. Journal of Psychoactive Drugs, 48(4), 243–252. https://doi.org/10.1080/02791072.2016.1202459
   PubMed Web of Science ®Google Scholar
• Halberstadt, A. L. (2015). Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behavioural Brain Research, 277, 99–120. https://doi.org/10.1016/j.bbr.2014.07.016
   PubMed Web of Science ®Google Scholar
• Hallock, R. M., Dean, A., Knecht, Z. A., Spencer, J., & Taverna, E. C. (2013). A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students. Drug and Alcohol Dependence, 130(1–3), 245–248. https://doi.org/10.1016/j.drugalcdep.2012.11.010
   PubMed Web of Science ®Google Scholar
• Hammersley, R., & Reid, M. (2002). Why the pervasive addiction myth is still believed. Addiction Research & Theory, 10(1), 7–30. https://doi.org/10.1080/16066350290001687
   Web of Science ®Google Scholar
• Hart, C. L. (2020). Exaggerating harmful drug effects on the brain is killing black people. Neuron, 107(2), 215–218. https://doi.org/10.1016/j.neuron.2020.06.019
   PubMed Web of Science ®Google Scholar
• Hart, C. L. (2021). Drug use for grown-ups: Chasing liberty in the land of fear. Penguin.
   Google Scholar
• Hartogsohn, I. (2017). Constructing drug effects: A history of set and setting. Drug Science Policy & Law, 3, 1–17.
   Google Scholar
• Hathaway, A. D. (1997). Marijuana and lifestyle: Exploring tolerable deviance. Deviant Behavior, 18(3), 213–232. https://doi.org/10.1080/01639625.1997.9968056
   Web of Science ®Google Scholar
• Hathaway, A. D., & Sharpley, J. (2010). The cannabis experience: An analysis of “flow”. In D. Jacquette (Ed.), Cannabis (pp. 50–61). Wiley-Blackwell.
   Google Scholar
• Hendricks, P. S. (2018). Awe: A putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy. International Review of Psychiatry, 30(4), 331–342. https://doi.org/10.1080/09540261.2018.1474185
   PubMed Web of Science ®Google Scholar
• Hendricks, P. S., Clark, C. B., Johnson, M. W., Fontaine, K. R., & Cropsey, K. L. (2014). Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision. Journal of Psychopharmacology, 28(1), 62–66. https://doi.org/10.1177/0269881113513851
   PubMed Web of Science ®Google Scholar
• Hendricks, P. S., Thorne, C. B., Clark, C. B., Coombs, D. W., & Johnson, M. W. (2015). Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. Journal of Psychopharmacology, 29(3), 280–288. https://doi.org/10.1177/0269881114565653
   PubMed Web of Science ®Google Scholar
• Heyman, G. M. (2010). Addiction: A disorder of choice. Harvard University Press.
   Google Scholar
• Institute of Medicine. (1996). Pathways of addiction: Opportunities in drug abuse research. National Academies Press.
   Google Scholar
• Ivsins, A., & Yake, K. (2020). Looking beyond harm: Meaning and purpose of substance use in the lives of marginalized people who use drugs. Drugs: Education, Prevention and Policy, 27, 27–36. https://doi.org/10.1080/09687637.2018.1497145
   Web of Science ®Google Scholar
• Jenkins, E. K., Slemon, A., & Haines-Saah, R. J. (2017). Developing harm reduction in the context of youth substance use: Insights from a multi-site qualitative analysis of young people’s harm minimization strategies. Harm Reduction Journal, 14(1), 1–11. https://doi.org/10.1186/s12954-017-0180-z
   PubMed Web of Science ®Google Scholar
• Johnson, M. W., & Griffiths, R. R. (2017). Potential therapeutic effects of psilocybin. Neurotherapeutics, 14(3), 734–740. https://doi.org/10.1007/s13311-017-0542-y
   PubMed Web of Science ®Google Scholar
• Johnson, M. W., Richards, W. A., & Griffiths, R. R. (2008). Human hallucinogen research: Guidelines for safety. Journal of Psychopharmacology, 22(6), 603–620. https://doi.org/10.1177/0269881108093587
   PubMed Web of Science ®Google Scholar
• Kettner, H., Rosas, F. E., Timmermann, C., Kärtner, L., Carhart-Harris, R. L., & Roseman, L. (2021). Psychedelic communitas: Intersubjective experience during psychedelic group sessions predicts enduring changes in psychological wellbeing and social connectedness. Frontiers in Pharmacology, 12, 623985. https://doi.org/10.3389/fphar.2021.623985
   PubMed Web of Science ®Google Scholar
• Kippin, T. E. (2011). Does drug mis-instrumentalization lead to drug abuse? The Behavioral and Brain Sciences, 34(6), 316–317. https://doi.org/10.1017/S0140525X11000859
   PubMed Web of Science ®Google Scholar
• Klerman, G. L. (1972). Psychotropic hedonism vs. pharmacological Calvinism. The Hastings Center Report, 2(4), 1–3. https://doi.org/10.2307/3561398
   PubMedGoogle Scholar
• Koob, G. F., Ahmed, S. H., Boutrel, B., Chen, S. A., Kenny, P. J., Markou, A., O'Dell, L. E., Parsons, L. H., & Sanna, P. P. (2004). Neurobiological mechanisms in the transition from drug use to drug dependence. Neuroscience and Biobehavioral Reviews, 27(8), 739–749. https://doi.org/10.1016/j.neubiorev.2003.11.007
   PubMed Web of Science ®Google Scholar
• Krebs, T. S., & Johansen, P. Ø. (2013). Over 30 million psychedelic users in the United States. F1000 Research, 2, 1–5.
   PubMedGoogle Scholar
• Leary, M. R., & Guadagno, J. (2011). The role of hypo-egoic self-processes in optimal functioning and subjective well-being. In T. B. Kashdan, K. M. Sheldon, & M. F. Steger (Eds.), Designing positive psychology: Taking stock and moving forward (pp. 135–146). Oxford University Press.
   Google Scholar
• Lerner, M., & Lyvers, M. (2006). Values and beliefs of psychedelic drug users: A cross-cultural study. Journal of Psychoactive Drugs, 38(2), 143–147. https://doi.org/10.1080/02791072.2006.10399838
   PubMed Web of Science ®Google Scholar
• Lewis, S. E. (2008). Ayahuasca and spiritual crisis: Liminality as space for personal growth. Anthropology of Consciousness, 19(2), 109–133. https://doi.org/10.1111/j.1556-3537.2008.00006.x
   Google Scholar
• Lyvers, M., & Meester, M. (2012). Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner. Journal of Psychoactive Drugs, 44(5), 410–417. https://doi.org/10.1080/02791072.2012.736842
   PubMed Web of Science ®Google Scholar
• McBride, N., Farringdon, F., Midford, R., Meuleners, L., & Phillips, M. (2004). Harm minimization in school drug education: Final results of the School Health and Alcohol Harm Reduction Project (SHAHRP). Addiction, 99(3), 278–291. https://doi.org/10.1111/j.1360-0443.2003.00620.x
   PubMed Web of Science ®Google Scholar
• McGovern, P. E. (2009). Uncorking the past: The quest for wine, beer, and other alcoholic beverages. University of California Press.
   Google Scholar
• Merlin, M. D. (2003). Archaeological evidence for the tradition of psychoactive plant use in the old world. Economic Botany, 57(3), 295–323. https://doi.org/10.1663/0013-0001(2003)057[0295:AEFTTO2.0.CO;2]
   Web of Science ®Google Scholar
• Moore, D. (2008). Erasing pleasure from public discourse on illicit drugs: On the creation and reproduction of an absence. International Journal of Drug Policy, 19(5), 353–358. https://doi.org/10.1016/j.drugpo.2007.07.004
   PubMed Web of Science ®Google Scholar
• Móró, L., & Noreika, V. (2011). Sacramental and spiritual use of hallucinogenic drugs. Behavioral and Brain Sciences, 34(6), 319–320. https://doi.org/10.1017/S0140525X11000768
   PubMed Web of Science ®Google Scholar
• Móró, L., Simon, K., Bárd, I., & Rácz, J. (2011). Voice of the psychonauts: Coping, life purpose, and spirituality in psychedelic drug users. Journal of Psychoactive Drugs, 43(3), 188–198. https://doi.org/10.1080/02791072.2011.605661
   PubMed Web of Science ®Google Scholar
• Mugford, S. (1988, August 22). Pathology, pleasure, profit and the state: Towards an integrated theory of drug use [Paper presentation]. The Australian and New Zealand Society of Criminology Annual Conference, Sydney, Australia.
   Google Scholar
• Müller, C. P., & Schumann, G. (2011). Drugs as instruments: A new framework for non-addictive psychoactive drug use. Behavioral and Brain Sciences, 34(6), 293–310. https://doi.org/10.1017/S0140525X11000057
   PubMed Web of Science ®Google Scholar
• Neighbors, C., Lee, C. M., Lewis, M. A., Fossos, N., & Larimer, M. E. (2007). Are social norms the best predictor of outcomes among heavy-drinking college students? Journal of Studies on Alcohol and Drugs, 68(4), 556–565. https://doi.org/10.15288/jsad.2007.68.556
   PubMed Web of Science ®Google Scholar
• Neitzke-Spruill, L., & Glasser, C. (2018). A gratuitous grace: The influence of religious set and intent on the psychedelic experience. Journal of Psychoactive Drugs, 50(4), 314–321. https://doi.org/10.1080/02791072.2018.1494869
   PubMed Web of Science ®Google Scholar
• Nichols, D. E. (2016). Psychedelics. Pharmacological Reviews, 68(2), 264–355. https://doi.org/10.1124/pr.115.011478
   PubMed Web of Science ®Google Scholar
• Nicholson, T., Duncan, D. F., & White, J. B. (2002). Is recreational drug use normal? Journal of Substance Use, 7(3), 116–123. https://doi.org/10.1080/14659890209169340
   Google Scholar
• Nicholson, T., White, J., & Duncan, D. F. (1999). A survey of adult recreational drug use via the World Wide Web: The DRUGNET study. Journal of Psychoactive Drugs, 31(4), 415–422. https://doi.org/10.1080/02791072.1999.10471771
   PubMed Web of Science ®Google Scholar
• Nour, M. M., & Carhart-Harris, R. L. (2017). Psychedelics and the science of self-experience. The British Journal of Psychiatry, 210(3), 177–179. https://doi.org/10.1192/bjp.bp.116.194738
   PubMed Web of Science ®Google Scholar
• Nour, M. M., Evans, L., Nutt, D., & Carhart-Harris, R. L. (2016). Ego-dissolution and psychedelics: Validation of the ego-dissolution inventory (EDI). Frontiers in Human Neuroscience, 10, 1–13. https://doi.org/10.3389/fnhum.2016.00269
   PubMed Web of Science ®Google Scholar
• Nutt, D. J., King, L. A., & Nichols, D. E. (2013). Effects of Schedule I drug laws on neuroscience research and treatment innovation. Nature Reviews. Neuroscience, 14(8), 577–585. https://doi.org/10.1038/nrn3530
   PubMed Web of Science ®Google Scholar
• Nutt, D. J., King, L. A., & Phillips, L. D. (2010). Drug harms in the UK: A multicriteria decision analysis. The Lancet, 376(9752), 1558–1565. https://doi.org/10.1016/S0140-6736(10)61462-6
   PubMed Web of Science ®Google Scholar
• Nutt, D., King, L. A., Saulsbury, W., & Blakemore, C. (2007). Development of a rational scale to assess the harm of drugs of potential misuse. The Lancet, 369(9566), 1047–1053. https://doi.org/10.1016/S0140-6736(07)60464-4
   PubMed Web of Science ®Google Scholar
• Osborne, G. B., & Fogel, C. (2017). Perspectives on cannabis legalization among Canadian recreational users. Contemporary Drug Problems, 44(1), 12–31. https://doi.org/10.1177/0091450916670393
   Google Scholar
• Parker, H., Williams, L., & Aldridge, J. (2002). The normalization of ‘sensible’ recreational drug use: Further evidence from the North West England longitudinal study. Sociology, 36(4), 941–964. https://doi.org/10.1177/003803850203600408
   Google Scholar
• Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008). The pharmacology of lysergic acid diethylamide: A review. CNS Neuroscience & Therapeutics, 14(4), 295–314. https://doi.org/10.1111/j.1755-5949.2008.00059.x
   PubMed Web of Science ®Google Scholar
• Passie, T., Seifert, J., Schneider, U., & Emrich, H. M. (2002). The pharmacology of psilocybin. Addiction Biology, 7(4), 357–364. https://doi.org/10.1080/1355621021000005937
   PubMed Web of Science ®Google Scholar
• Peele, S. (1999). Promoting positive drinking: Alcohol, necessary evil or positive good? In S. Peele & M. Grant (Eds.), Alcohol and pleasure: A health perspective (pp. 375–389). Brunner/Mazel.
   Google Scholar
• Peele, S., & Brodsky, A. (2000). Exploring psychological benefits associated with moderate alcohol use: A necessary corrective to assessments of drinking outcomes? Drug and Alcohol Dependence, 60(3), 221–247. https://doi.org/10.1016/s0376-8716(00)00112-5
   PubMed Web of Science ®Google Scholar
• Pennay, A. (2015). “What goes up must go down”: An exploration of the relationship between drug-related pleasure and harm experienced by a sample of regular “party drug” users. Drugs: Education, Prevention and Policy, 22, 185–192. https://doi.org/10.3109/09687637.2015.1016398
   Web of Science ®Google Scholar
• Pickard, H. (2011). The instrumental rationality of addiction. Behavioral and Brain Sciences, 34(6), 320–321. https://doi.org/10.1017/S0140525X1100077X
   PubMed Web of Science ®Google Scholar
• Prepeliczay, S. (2002). Socio-cultural and psychological aspects of contemporary LSD use in Germany. Journal of Drug Issues, 32(2), 431–458. https://doi.org/10.1177/002204260203200207
   Web of Science ®Google Scholar
• Public Health Agency of Canada. (2015). The chief public health officer’s report on the state of public health in Canada 2015 - Alcohol consumption in Canada. Public Health Agency of Canada.
   Google Scholar
• Redish, A. D., Jensen, S., & Johnson, A. (2008). A unified framework for addiction: Vulnerabilities in the decision process. Behavioral and Brain Sciences, 31(4), 415–487. https://doi.org/10.1017/S0140525X0800472X
   PubMed Web of Science ®Google Scholar
• Reneau, J., Nicholson, T., White, J. B., & Duncan, D. (2000). The general well-being of recreational drug users: A survey on the WWW. The International Journal on Drug Policy, 11(5), 315–323. https://doi.org/10.1016/s0955-3959(00)00049-9
   PubMedGoogle Scholar
• Rosenthal, G. A., Janzen, D. H., & Applebaum, S. W. (Eds.) (1978). Herbivores: Their interactions with secondary plant metabolites. Academic Press.
   Google Scholar
• Ross, A., Potter, G. R., Barratt, M. J., & Aldridge, J. A. (2020). “Coming Out”: Stigma, Reflexivity and the Drug Researcher’s Drug Use. Contemporary Drug Problems, 47(4), 268–285. https://doi.org/10.1177/0091450920953635
   Google Scholar
• Rudd, M., Vohs, K. D., & Aaker, J. (2012). Awe expands people’s perception of time, alters decision making, and enhances well-being. Psychological Science, 23(10), 1130–1136. https://doi.org/10.1177/0956797612438731
   PubMed Web of Science ®Google Scholar
• Samorini, G. (2001). New data on the ethnomycology of psychoactive mushrooms. International Journal of Medicinal Mushrooms, 3(2–3), 1–22. https://doi.org/10.1615/IntJMedMushr.v3.i2-3.1670
   Google Scholar
• Seligman, M. E. (1999). The president’s address. American Psychologist, 54, 559–562.
   Web of Science ®Google Scholar
• Seligman, M. E. (2002). Positive psychology, positive prevention, and positive therapy. In C. R. Snyder & S. J. Lopez (Eds.), Handbook of positive psychology (pp. 3–9). Oxford University Press.
   Google Scholar
• Sheldon, K. M., & King, L. (2001). Why positive psychology is necessary. American Psychologist, 56(3), 216–217. https://doi.org/10.1037/0003-066X.56.3.216
   PubMed Web of Science ®Google Scholar
• Siegel, R. (1989). Intoxication: Life in pursuit of artificial paradise. E. P. Dutton.
   Google Scholar
• Simons, J., Correia, C. J., & Carey, K. B. (2000). A comparison of motives for marijuana and alcohol use among experienced users. Addictive Behaviors, 25(1), 153–160. https://doi.org/10.1016/s0306-4603(98)00104-x
   PubMed Web of Science ®Google Scholar
• Simons, J., Correia, C. J., Carey, K. B., & Borsari, B. E. (1998). Validating a five-factor marijuana motives measure: Relations with use, problems, and alcohol motives. Journal of Counseling Psychology, 45(3), 265–273. https://doi.org/10.1037/0022-0167.45.3.265
   Web of Science ®Google Scholar
• Slemon, A., Jenkins, E. K., Haines-Saah, R. J., Daly, Z., & Jiao, S. (2019). “You can’t chain a dog to a porch”: A multisite qualitative analysis of youth narratives of parental approaches to substance use. Harm Reduction Journal, 16(1), 1–10. https://doi.org/10.1186/s12954-019-0297-3
   PubMedGoogle Scholar
• Smyth, N. J., & Kost, K. A. (1998). Exploring the nature of the relationship between poverty and substance abuse: Knowns and unknowns. Journal of Human Behavior in the Social Environment, 1(1), 67–82. https://doi.org/10.1300/J137v01n01_05
   Google Scholar
• Souleymanov, R., & Allman, D. (2016). Articulating connections between the harm-reduction paradigm and the marginalisation of people who use illicit drugs. British Journal of Social Work, 46(5), 1429–1445. https://doi.org/10.1093/bjsw/bcv067
   Web of Science ®Google Scholar
• Spear, L. P. (2000). The adolescent brain and age-related behavioral manifestations. Neuroscience and Biobehavioral Reviews, 24(4), 417–463. https://doi.org/10.1016/s0149-7634(00)00014-2
   PubMed Web of Science ®Google Scholar
• Stasko, A., Rao, S. P., & Pilley, A. (2012). Spirituality and hallucinogen use: Results from a pilot study among college students. International Journal of Transpersonal Studies, 31(2), 23–32. https://doi.org/10.24972/ijts.2012.31.2.23
   Google Scholar
• Strassman, R. J. (1984). Adverse reactions to psychedelic drugs. A review of the literature. The Journal of Nervous and Mental Disease, 172(10), 577–595. https://doi.org/10.1097/00005053-198410000-000016384428
   Google Scholar
• Tart, C. T. (2000). States of consciousness. Backinprint.com.
   Google Scholar
• Taylor, S., Buchanan, J., & Ayres, T. (2016). Prohibition, privilege and the drug apartheid: The failure of drug policy reform to address the underlying fallacies of drug prohibition. Criminology & Criminal Justice, 16(4), 452–469. https://doi.org/10.1177/1748895816633274
   Web of Science ®Google Scholar
• Tupper, K. W. (2008). Teaching teachers to just say “know”: Reflections on drug education. Teaching and Teacher Education, 24(2), 356–367. https://doi.org/10.1016/j.tate.2007.08.007
   Web of Science ®Google Scholar
• Tutenges, S., Kolind, T., & Uhl, A. (2015). Explorations into the drug users’ perspectives. Drugs: Education, Prevention and Policy, 22, 173–174. https://doi.org/10.3109/09687637.2015.1047324
   Web of Science ®Google Scholar
• Tylš, F., Páleníček, T., & Horáček, J. (2014). Psilocybin-summary of knowledge and new perspectives. European Neuropsychopharmacology, 24(3), 342–356. https://doi.org/10.1016/j.euroneuro.2013.12.006
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime. (2015). World drug report 2015. https://www.unodc.org/documents/wdr2015/World_Drug_Report_2015.pdf
   Google Scholar
• Valentine, K., & Fraser, S. (2008). Trauma, damage and pleasure: Rethinking problematic drug use. International Journal of Drug Policy, 19(5), 410–416. https://doi.org/10.1016/j.drugpo.2007.08.001
   PubMed Web of Science ®Google Scholar
• van Amsterdam, J., Opperhuizen, A., Koeter, M., & van den Brink, W. (2010). Ranking the harm of alcohol, tobacco and illicit drugs for the individual and the population. European Addiction Research, 16(4), 202–207. https://doi.org/10.1159/000317249
   PubMed Web of Science ®Google Scholar
• van Cappellen, P., & Saroglou, V. (2012). Awe activates religious and spiritual feelings and behavioral intentions. Psychology of Religion and Spirituality, 4(3), 223–236. https://doi.org/10.1037/a0025986
   Web of Science ®Google Scholar
• Vardy, M. M., & Kay, S. R. (1983). LSD Psychosis or LSD-Induced schizophrenia? A multimethod inquiry. Archives of General Psychiatry, 40(8), 877–883. https://doi.org/10.1001/archpsyc.1983.01790070067008
   PubMed Web of Science ®Google Scholar
• Walsh, Z., Hendricks, P. S., Smith, S., Kosson, D. S., Thiessen, M. S., Lucas, P., & Swogger, M. T. (2016). Hallucinogen use and intimate partner violence: Prospective evidence consistent with protective effects among men with histories of problematic substance use. Journal of Psychopharmacology, 30(7), 601–607. https://doi.org/10.1177/0269881116642538
   PubMed Web of Science ®Google Scholar
• Yaden, D. B., Haidt, J., Hood, R. W., Jr., Vago, D. R., & Newberg, A. B. (2017). The varieties of self-transcendent experience. Review of General Psychology, 21(2), 143–160. https://doi.org/10.1037/gpr0000102
   Web of Science ®Google Scholar
• Young, M., Stuber, J., Ahern, J., & Galea, S. (2005). Interpersonal discrimination and the health of illicit drug users. The American Journal of Drug and Alcohol Abuse, 31(3), 371–391. https://doi.org/10.1081/ADA-200056772
   PubMed Web of Science ®Google Scholar
• Zinberg, N. E. (1984). Drug, set, and setting: The basis for controlled intoxicant use. Yale University.
   Google Scholar